Avanos Medical Stock Return On Equity

AVNS Stock

USD 19.14 0.02 0.10%

Avanos Medical fundamentals help investors to digest information that contributes to Avanos Medical's financial success or failures. It also enables traders to predict the movement of Avanos Stock. The fundamental analysis module provides a way to measure Avanos Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avanos Medical stock.

		Last Reported	Projected for Next Year
	Return On Equity	(0.05)	(0.05)

Return On Equity is likely to gain to -0.05 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Avanos Medical Company Return On Equity Analysis

Avanos Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Avanos Medical Return On Equity

0.0177

Most of Avanos Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Avanos Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Avanos Medical is extremely important. It helps to project a fair market value of Avanos Stock properly, considering its historical fundamentals such as Return On Equity. Since Avanos Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avanos Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avanos Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	0.0	-0.19	0.78	0.84	0.94	0.95	0.75	0.2	0.19	0.81	0.01	0.22	0.63	0.88	0.88	0.16	0.35	0.02	-0.03	0.06	0.03	0.08
Total Stockholder Equity	0.91		0.06	-0.06	0.53	0.68	0.81	0.92	0.44	0.01	-0.08	0.64	-0.13	-0.03	0.68	0.84	0.85	0.09	0.01	-0.14	0.11	-0.15	-0.14	-0.1
Net Tangible Assets	0.0	0.06		-0.55	-0.08	-0.45	0.02	-0.2	-0.07	0.11	-0.4	0.28	-0.68	-0.4	0.46	0.35	-0.33	0.71	-0.29	-0.85	0.53	-0.71	-0.79	-0.17
Retained Earnings	-0.19	-0.06	-0.55		-0.29	0.04	-0.36	0.02	-0.42	-0.76	-0.5	-0.41	0.53	-0.5	-0.47	-0.53	-0.05	-0.96	-0.36	0.52	-0.45	0.51	0.52	0.28
Accounts Payable	0.78	0.53	-0.08	-0.29		0.82	0.82	0.67	0.9	0.28	0.49	0.85	0.3	0.48	0.29	0.63	0.64	0.22	0.54	0.26	-0.27	0.28	0.31	0.14
Long Term Debt	0.84	0.68	-0.45	0.04	0.82		0.82	0.84	0.78	0.13	0.43	0.69	0.45	0.45	0.21	0.55	0.84	-0.16	0.53	0.54	-0.39	0.5	0.54	0.18
Net Receivables	0.94	0.81	0.02	-0.36	0.82	0.82		0.87	0.84	0.32	0.32	0.84	-0.03	0.34	0.58	0.88	0.83	0.31	0.52	0.01	0.02	-0.02	0.0	-0.07
Good Will	0.95	0.92	-0.2	0.02	0.67	0.84	0.87		0.62	0.05	0.15	0.62	0.09	0.19	0.53	0.78	0.95	-0.05	0.28	0.11	-0.09	0.11	0.1	0.08
Total Liab	0.75	0.44	-0.07	-0.42	0.9	0.78	0.84	0.62		0.47	0.55	0.82	0.16	0.54	0.33	0.65	0.59	0.32	0.81	0.22	-0.13	0.23	0.23	0.09
Deferred Long Term Liab	0.2	0.01	0.11	-0.76	0.28	0.13	0.32	0.05	0.47		0.62	0.31	-0.41	0.62	0.5	0.42	0.1	0.7	0.52	-0.17	0.45	-0.19	-0.21	-0.26
Short Long Term Debt	0.19	-0.08	-0.4	-0.5	0.49	0.43	0.32	0.15	0.55	0.62		0.18	0.28	1.0	-0.08	0.16	0.35	0.26	0.64	0.37	-0.25	0.34	0.36	0.14
Total Current Assets	0.81	0.64	0.28	-0.41	0.85	0.69	0.84	0.62	0.82	0.31	0.18		-0.02	0.19	0.52	0.77	0.5	0.41	0.43	0.0	0.02	0.0	0.04	-0.06
Treasury Stock	0.01	-0.13	-0.68	0.53	0.3	0.45	-0.03	0.09	0.16	-0.41	0.28	-0.02		0.27	-0.62	-0.39	0.17	-0.68	0.16	0.87	-0.81	0.88	0.9	0.5
Short Term Debt	0.22	-0.03	-0.4	-0.5	0.48	0.45	0.34	0.19	0.54	0.62	1.0	0.19	0.27		-0.04	0.19	0.39	0.26	0.62	0.36	-0.23	0.32	0.35	0.13
Intangible Assets	0.63	0.68	0.46	-0.47	0.29	0.21	0.58	0.53	0.33	0.5	-0.08	0.52	-0.62	-0.04		0.83	0.43	0.59	0.0	-0.58	0.59	-0.52	-0.61	-0.26
Common Stock	0.88	0.84	0.35	-0.53	0.63	0.55	0.88	0.78	0.65	0.42	0.16	0.77	-0.39	0.19	0.83		0.72	0.56	0.27	-0.4	0.37	-0.37	-0.39	-0.19
Property Plant Equipment	0.88	0.85	-0.33	-0.05	0.64	0.84	0.83	0.95	0.59	0.1	0.35	0.5	0.17	0.39	0.43	0.72		-0.05	0.31	0.18	-0.17	0.16	0.16	0.1
Current Deferred Revenue	0.16	0.09	0.71	-0.96	0.22	-0.16	0.31	-0.05	0.32	0.7	0.26	0.41	-0.68	0.26	0.59	0.56	-0.05		0.2	-0.69	0.6	-0.68	-0.69	-0.39
Net Debt	0.35	0.01	-0.29	-0.36	0.54	0.53	0.52	0.28	0.81	0.52	0.64	0.43	0.16	0.62	0.0	0.27	0.31	0.2		0.36	-0.15	0.29	0.32	0.04
Long Term Debt Total	0.02	-0.14	-0.85	0.52	0.26	0.54	0.01	0.11	0.22	-0.17	0.37	0.0	0.87	0.36	-0.58	-0.4	0.18	-0.69	0.36		-0.7	0.91	0.98	0.32
Capital Surpluse	-0.03	0.11	0.53	-0.45	-0.27	-0.39	0.02	-0.09	-0.13	0.45	-0.25	0.02	-0.81	-0.23	0.59	0.37	-0.17	0.6	-0.15	-0.7		-0.8	-0.78	-0.72
Net Invested Capital	0.06	-0.15	-0.71	0.51	0.28	0.5	-0.02	0.11	0.23	-0.19	0.34	0.0	0.88	0.32	-0.52	-0.37	0.16	-0.68	0.29	0.91	-0.8		0.95	0.66
Net Working Capital	0.03	-0.14	-0.79	0.52	0.31	0.54	0.0	0.1	0.23	-0.21	0.36	0.04	0.9	0.35	-0.61	-0.39	0.16	-0.69	0.32	0.98	-0.78	0.95		0.44
Capital Stock	0.08	-0.1	-0.17	0.28	0.14	0.18	-0.07	0.08	0.09	-0.26	0.14	-0.06	0.5	0.13	-0.26	-0.19	0.1	-0.39	0.04	0.32	-0.72	0.66	0.44

Click cells to compare fundamentals

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Avanos Medical

Return On Equity Over Time

Avanos Total Stockholder Equity

Total Stockholder Equity

1.41 Billion

At this time, Avanos Medical's Total Stockholder Equity is comparatively stable compared to the past year.

Based on the latest financial disclosure, Avanos Medical has a Return On Equity of 0.0177. This is 100.07% lower than that of the Health Care Equipment & Supplies sector and 100.2% lower than that of the Health Care industry. The return on equity for all United States stocks is 105.71% lower than that of the firm.

Avanos Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.

Avanos Medical is currently under evaluation in return on equity category among its peers.

Avanos Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avanos Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avanos Medical's managers, analysts, and investors.

Environmental

Governance

Social

Avanos Fundamentals

	Return On Equity	0.0177
	Return On Asset	0.0208
	Profit Margin	0.02 %
	Operating Margin	0.1 %
	Current Valuation	1 B
	Shares Outstanding	45.96 M
	Shares Owned By Insiders	2.94 %
	Shares Owned By Institutions	96.00 %
	Number Of Shares Shorted	552.33 K
	Price To Earning	51.23 X
	Price To Book	0.72 X
	Price To Sales	1.29 X
	Revenue	673.3 M
	Gross Profit	450 M
	EBITDA	50.6 M
	Net Income	(61.8 M)
	Cash And Equivalents	106.5 M
	Cash Per Share	2.26 X
	Total Debt	209.1 M
	Debt To Equity	0.24 %
	Current Ratio	2.89 X
	Book Value Per Share	26.73 X
	Cash Flow From Operations	32.4 M
	Short Ratio	2.14 X
	Earnings Per Share	0.47 X
	Price To Earnings To Growth	2.29 X
	Target Price	22.5
	Number Of Employees	3.77 K
	Beta	0.93
	Market Capitalization	880.54 M
	Total Asset	1.69 B
	Retained Earnings	(314.9 M)
	Working Capital	252.4 M
	Current Asset	773.54 M
	Current Liabilities	415.63 M
	Net Asset	1.69 B

About Avanos Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC